USFDA grants ‘tentative approval’ to Zydus’ mental health drug
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Alembic Pharma receives USFDA approval for breast cancer drug--Fulvestrant injection
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
The FDA has told healthcare providers to consider different MRI-guided breast biopsy procedure options due to a shortage of grid plates and coil.
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA.
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.
September 22, 2022: Lupin Ltd., one of the top Indian pharmaceutical majors, has received approval from the US drug regulator United States Food.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com